Author Archive: Abigail Hirsch

Abigail Hirsch

Abigail is the Director of Events Communications at BIO. Although she has lived in the Washington, DC, area for nearly eight years, she still considers Virginia Beach home, especially with her parents and closest friends still in the area. According to Abigail, there is nothing better than sitting on the beach with a good book and cold drink. In her spare time, she enjoys visiting antique stores, finishing her twin sister Brooke’s sentences and spending time with her two boys, Frank her English bulldog, and JP her soon-to-be husband. Check back often for updates, Abigail’s take on BIO related events, and much more. And please, be kind, this is her first venture in to the blogging world!

Latest Posts

BIO Housing Inventory Going Fast

Chicago

With roughly 80,000 bioscience jobs in more than 3,500 businesses across all bioscience sectors, it is no wonder the 2013 BIO International Convention is returning to Chicago, April 22- 25, 2013. With a large presence in all biotech sectors – agricultural feedstock and chemicals, drugs and pharma, medical devices and equipment, research, testing and medical laboratories and bioscience-related distribution, attendees will have the opportunity to meet with and visit premier R&D facilities, from national laboratories Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

Tips for Building Your Brand at the 2013 BIO International Convention

exhibit-floor

Anxious to get a head start on your Convention planning but don’t know where to begin? Join the BIO Convention team’s monthly webinar series. Open to all attendees, pavilion organizers, delegations and prospective attendees, the webinar gives direct access to the drivers of the event, BIO staff. Last week’s webinar, Branding at BIO, focused on what to expect for exhibitor booth partnering, cost and time saving tips when dealing with Chicago union labor and how to Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Investor Forum – Raring to Go: The Race to Treat Ultra-Rare Diseases

BIO Investor Forum

The signing of FDASIA by President Obama in July reinforces the country’s commitment to fostering innovation for rare diseases. With a record 460 medicines in late-stage clinical trials, biopharmaceutical companies have embraced rare disease medicine and are rapidly developing the pipeline. In anticipation of an even more compelling opportunity, many companies are taking a step beyond and focusing on ultra rare diseases. Last week’s 11th Annual BIO Investor Forum in San Francisco hosted a panel, Raring Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

BIO Travels to Brazil to Support the Ecosystem of Innovation

Refinery

Government policies that support innovation are critical as the biotechnology industry seeks to develop innovative healthcare, agricultural, industrial and environmental biotechnology products and provide them to people all around the world. Innovation requires not only scientific research and commercial expertise, but also supportive and dynamic governments that help facilitate long-term growth of the industry. Brazil has recognized the value of innovation in maintaining a robust, diversified economy that can compete in the 21st century, and declared Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

2012 BIO Technology Transfer Symposium

tt-symp

BIO’s Technology Transfer Symposium is right around the corner, next Monday, October 8th in fact. And whether you are planning on attending the BIO Investor Forum, the Tech Transfer offers a unique insight in to the value of biotech public-private partnerships. The Tech Transfer highlights recent and successful early stage technology transfer deals from a variety of perspectives, including universities, government and venture capitalists. Attendees will learn about how technology transfer offices and industry are working Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,